The Institute of Quality at the Confederation of Indian Industries (CII) is organising a two-day international conference on clinical trials at Mumbai from October 23 to create widespread sensitisation on clinical trial methodology and to provide an in-depth knowledge on the subject.
The conference on 'drug discovery to final product' will bring together all stakeholders dealing directly and indirectly in the area.
Scientific sessions on different streams of clinical research operations, pharmacovigilance, regulatory affairs, qualification validation, and safety audit will be conducted at the conference, according to the organisers.
"India is the signatory of the WTO agreement and the second largest populated country in the world with large pool of patient population, well-developed hospitals, talented work force, and strong regulatory environment. Many of the companies globally are looking for an alternative destination to conduct trials," according to a release.
With the robust infrastructural set up, India can emerge as a preferred destination for clinical research and play a key role in drug discovery to final product process. India on the regulatory side also has taken a number of initiatives to provide a good environment, the release added.
Academicians, clinical development groups, medical directors, clinical research associates, project personnel, data personnel, report writers, regulatory officials and biostatisticians can attend the conference, to be guided by experts in the field.
The topics to be covered in the event includes global procedures in clinical research, principles of good clinical laboratory practices, GCP operations, ISO 15189:2007 for laboratory accreditation, auditing of trials, generation and maintenance of SOPs, testing and calibration, corrective and preventive actions, document management and control and qualification and validation.